Placenta Accreta

Subscribe to Selected New Research on Placenta Accreta

306 relevant articles (0 outcomes, 11 trials/studies) found for this Disease

Description: Abnormal placentation in which all or parts of the PLACENTA are attached directly to the MYOMETRIUM due to a complete or partial absence of DECIDUA. It is associated with POSTPARTUM HEMORRHAGE because of the failure of placental separation.

Also Known As:

Placenta Increta; Placenta Percreta; Accreta, Placenta; Increta, Placenta; Percreta, Placenta

Disease Context: Research Results

Female Urogenital Diseases and Pregnancy Complications

Pregnancy Complications: 515

Obstetric Labor Complications: 21

Placenta Accreta: 306

Placenta Diseases: 14

Placenta Accreta: 306

Related Diseases

1.	Placenta Previa
2.	Uterine Rupture
3.	Uterine Inertia
4.	Spontaneous Abortion (Miscarriage)
5.	Choriocarcinoma
62 Diseases and 162 more articles analyzed in the Research Interface, order at left...

Experts

1.	Ho, Esther Shih C: 3 articles (02/2006 - 09/2003)
2.	Chou, Min M: 3 articles (02/2006 - 09/2003)
3.	Tseng, Jenn J: 3 articles (02/2006 - 09/2003)
4.	Hsu, Shih L: 2 articles (02/2006 - 12/2004)
5.	Wen, Mei C: 2 articles (02/2006 - 12/2004)
6.	Clark, V: 1 article (07/2008)
7.	Gillespie, I: 1 article (07/2008)
8.	Arnadottir, Berglind Thóra: 1 article (07/2008)
9.	Dundas, K: 1 article (07/2008)
10.	Mok, M: 1 article (07/2008)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Placenta Accreta:

1.	ParaffinIBA 06/01/1998 - "METHODS: The immunoperoxidase technique with an antibody directed against eNOS was applied to paraffin sections from first and second trimester placentas, placenta accreta, partial and complete hydatidiform moles, and choriocarcinoma" 12/01/2004 - "STUDY DESIGN: Paraffin sections of 43 placental specimens with (cases) and 43 without (controls) placenta accreta were studied immunohistochemically for epidermal growth factor receptor and c-erbB-2 expression in the syncytiotrophoblast, villous cytotrophoblast, and extravillous cytotrophoblast" 02/01/2006 - "STUDY DESIGN: Paraffin sections of 46 placental specimens with (cases) and 46 without (controls) placenta accreta were studied immunohistochemically for the expression of Tie receptors and angiopoietin-2 in trophoblast populations" Get all the results and reference details, order at left...
2.	Angiopoietin-2IBA 02/01/2006 - "CONCLUSION: These observations suggest that the participation of up-regulated angiopoietin-2 and down-regulated Tie-2 in the placental tissues may indicate a role for these angiogenic factors in the development of placenta accreta." 02/01/2006 - "Enzyme-linked immunosorbent assay in the placental lysates showed that women with placenta accreta demonstrated significantly higher angiopoietin-2 and lower Tie-2 concentrations than did women with normal pregnancies (P = .026 and .003, respectively)" 06/01/2006 - "We have found, in pregnancies complicated by placenta accreta: upregulated epidermal growth factor receptor and downregulated c-erbB-2 oncoprotein in syncytiotrophoblasts; downregulated vasculoendothelial growth factor receptor-2 expression in syncytiotrophoblasts and increased vasculoendothelial growth factor in placental lysates; and downregulated Tie-2 expression in syncytiotrophoblasts and enhanced angiopoietin-2 level in placental lysates" 02/01/2006 - "STUDY DESIGN: Paraffin sections of 46 placental specimens with (cases) and 46 without (controls) placenta accreta were studied immunohistochemically for the expression of Tie receptors and angiopoietin-2 in trophoblast populations" 02/01/2006 - "OBJECTIVE: The purpose of this study was to investigate the differential expression of angiopoietin-1, angiopoietin-2, and Tie receptors (Tie-1 and Tie-2) in placentas from pregnancies complicated by placenta accreta" Get all the results and reference details, order at left...
3.	Epidermal Growth Factor Receptor (EGF Receptor)IBA 12/01/2004 - "OBJECTIVE: The purpose of this study was to investigate the expression of epidermal growth factor receptor and c-erbB-2 oncoprotein in trophoblast populations of placenta accreta" 12/01/2004 - "CONCLUSION: The development of placenta accreta is related closely to the differential expression of epidermal growth factor receptor and c-erbB-2 in the syncytiotrophoblast." 12/01/2004 - "Expression of epidermal growth factor receptor and c-erbB-2 oncoprotein in trophoblast populations of placenta accreta." 12/01/2004 - "STUDY DESIGN: Paraffin sections of 43 placental specimens with (cases) and 43 without (controls) placenta accreta were studied immunohistochemically for epidermal growth factor receptor and c-erbB-2 expression in the syncytiotrophoblast, villous cytotrophoblast, and extravillous cytotrophoblast" 06/01/2006 - "We have found, in pregnancies complicated by placenta accreta: upregulated epidermal growth factor receptor and downregulated c-erbB-2 oncoprotein in syncytiotrophoblasts; downregulated vasculoendothelial growth factor receptor-2 expression in syncytiotrophoblasts and increased vasculoendothelial growth factor in placental lysates; and downregulated Tie-2 expression in syncytiotrophoblasts and enhanced angiopoietin-2 level in placental lysates" Get all the results and reference details, order at left...
4.	TIE Receptors (TIE Receptor Tyrosine Kinases)IBA 02/01/2006 - "STUDY DESIGN: Paraffin sections of 46 placental specimens with (cases) and 46 without (controls) placenta accreta were studied immunohistochemically for the expression of Tie receptors and angiopoietin-2 in trophoblast populations" 02/01/2006 - "OBJECTIVE: The purpose of this study was to investigate the differential expression of angiopoietin-1, angiopoietin-2, and Tie receptors (Tie-1 and Tie-2) in placentas from pregnancies complicated by placenta accreta" 02/01/2006 - "Differential expression of angiopoietin-1, angiopoietin-2, and Tie receptors in placentas from pregnancies complicated by placenta accreta." Get all the results and reference details, order at left...
5.	Angiopoietin-1IBA 02/01/2006 - "OBJECTIVE: The purpose of this study was to investigate the differential expression of angiopoietin-1, angiopoietin-2, and Tie receptors (Tie-1 and Tie-2) in placentas from pregnancies complicated by placenta accreta" 02/01/2006 - "Differential expression of angiopoietin-1, angiopoietin-2, and Tie receptors in placentas from pregnancies complicated by placenta accreta." Get all the results and reference details, order at left...
6.	Formaldehyde (Formol)IBA 01/01/1989 - "To study immunocytochemical PP19 localization in extravillous trophoblast, we obtained formalin-fixed specimens from extravillous tubal pregnancy at gestational weeks (GW) 7-9 (12 blocks); four early intrauterine pregnancies at GW 7-13 (12 blocks); four late pregnancies at GW 28-38 complicated with intramural uterine myoma, placenta increta and abruptio placenta (8 blocks); four invasive complete moles (9 blocks); and seven primary and metastatic gestational choriocarcinomas (12 blocks)" Get all the results and reference details, order at left...
7.	Dihydrotachysterol (AT 10)IBA 01/01/2003 - "METHODS: Patients who had a diagnosis of placenta accreta, increta, or percreta by clinical course or pathologic examination of the uterus and who had had a sonographic examination at 10 weeks or earlier were included in this study" 01/01/2003 - "CONCLUSIONS: In a patient with a previous cesarean delivery, a sac lying in the lower uterine segment on a scan at 10 weeks or earlier suggests the possibility of placenta accreta." Get all the results and reference details, order at left...
8.	placental protein 19IBA 01/01/1989 - "To study immunocytochemical PP19 localization in extravillous trophoblast, we obtained formalin-fixed specimens from extravillous tubal pregnancy at gestational weeks (GW) 7-9 (12 blocks); four early intrauterine pregnancies at GW 7-13 (12 blocks); four late pregnancies at GW 28-38 complicated with intramural uterine myoma, placenta increta and abruptio placenta (8 blocks); four invasive complete moles (9 blocks); and seven primary and metastatic gestational choriocarcinomas (12 blocks)" Get all the results and reference details, order at left...
9.	Methotrexate (Mexate)FDA LinkGeneric 07/01/2008 - "Case report: seventeen year old primipara with placenta increta, treated with methotrexate]" 02/01/2008 - "Placenta percreta was treated conservatively with methotrexate" 02/01/2008 - "Placenta percreta: methotrexate treatment and MRI findings." 01/01/2008 - "Three cases of partial placenta increta managed with methotrexate are described" 01/01/2008 - "The reported experience of methotrexate treatment in the conservative management of placenta accreta is scant" Get all the results and reference details, order at left...
10.	alpha-Fetoproteins (AFP)IBA 09/01/2003 - "Life-threatening obstetric haemorrhage in second trimester from a placenta percreta with raised alpha-fetoprotein levels." 03/01/1997 - "Elevated mid-trimester maternal serum x-fetoprotein (MSAFP) frequently leads to a suspicion of the abnormal placentation, and magnetic resonance imaging (MRI) can clearly identify the placenta accreta/increta" 08/01/1994 - "This case of placenta percreta diagnosed in the second trimester was associated with an elevated maternal serum alpha-fetoprotein level" 08/01/1993 - "OBJECTIVE: To determine whether placenta accreta/percreta/increta is associated with elevation of second-trimester maternal serum alpha-fetoprotein (MSAFP) levels" 08/01/1993 - "Placenta accreta is associated with elevated maternal serum alpha-fetoprotein." Get all the results and reference details, order at left...
52 Drugs and Important Bio-Agents and 70 more articles analyzed in the Research Interface, order at left...

Therapies and Procedures

1.	Hysterectomy 10/01/2007 - "OBJECTIVE: The objective of the study was to compare outcomes of women with placenta accreta who underwent cesarean hysterectomy with and without prophylactic intravascular balloon catheters" 08/01/1993 - "Twenty women had placenta accreta/percreta/increta (study group) and 24 underwent cesarean hysterectomy for other indications (control group)" 10/01/2008 - "Pregnancy termination was complicated by placenta increta, which required immediate abdominal hysterectomy" 07/04/2008 - "In confirmed placenta accreta cases, the amount of blood loss and blood transfused at delivery and subsequent emergency hysterectomy were analysed in respect to the presence/absence of antenatal diagnosis and the management at delivery" 07/04/2008 - "METHOD: The perinatal database and medical records for women who delivered in the period 2000-6 in a teaching hospital in New Zealand with a diagnosis of placenta accreta or postpartum haemorrhage or hysterectomy were reviewed" Get all the results and reference details, order at left...
2.	Cesarean Section (Caesarean Section) 07/01/2008 - "Through our experience, we have developed a unit protocol for the management of women with suspected placenta accreta undergoing caesarean section." 07/01/2008 - "Interventional radiology in women with suspected placenta accreta undergoing caesarean section." 06/01/2008 - "Placenta accreta is becoming more common, a sequelae to the rising caesarean section rate" 06/01/2008 - "PATIENT(S): A 32-year-old woman was diagnosed with a cervico-isthmic pregnancy and an anterior placenta percreta at 34 weeks' gestation at delivery by a cesarean section" 04/01/2008 - "Placenta accreta associated with previous cesarean section is the predominant risk factor for GH." Get all the results and reference details, order at left...
3.	Balloon Occlusion 11/01/2007 - "MATERIALS AND METHODS: Over a 30-month period, 11 patients with placenta accreta or its variants underwent cesarean delivery after bilateral internal iliac artery occlusion balloon placement (study group)" 07/01/2008 - "The obstetricians and anaesthetists in our institution are of the impression that the use of peri-operative, preferably pre-operative, internal iliac artery catheterization with or without balloon occlusion or embolisation, in women with placenta accreta or percreta, improves the operative field and potentially reduces blood loss and transfusion requirements" 11/01/2007 - "CONCLUSION: Perioperative internal iliac artery occlusion balloon placement is a safe and minimally invasive technique that reduces intraoperative blood loss and transfusion requirements in patients with placenta accreta and its variants undergoing cesarean delivery." 11/01/2007 - "Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta." 05/01/2006 - "PURPOSE: To determine what role, if any, prophylactic temporary balloon occlusion and transcatheter embolization of the anterior division of the internal iliac arteries plays in the management of patients with placenta accreta/percreta" Get all the results and reference details, order at left...
4.	Dilatation and Curettage (D&C) 10/01/2007 - "This is the first report of a placenta increta detected as a uterine mass after first-trimester dilatation and curettage, and its MRI findings." 10/01/2007 - "Placenta increta after first-trimester dilatation and curettage manifesting as an unusual uterine mass: magnetic resonance findings." 05/01/1999 - "Placenta increta complicating first-trimester D&C." 03/01/2005 - "CONCLUSIONS: Endomyometrial injury is frequent at termination or dilatation and curettage after miscarriage, but the relation to subsequent placenta accreta remains unclear" 03/01/2005 - "AIMS: To determine the frequency with which myometrium is removed during vacuum terminations of pregnancy or dilatation and curettage after miscarriage, and to relate these findings to subsequent placenta accreta or its proxies" Get all the results and reference details, order at left...
5.	Laparotomy 08/01/2006 - "Laparotomy for suspected abruption at 37 weeks revealed ruptured rudimentary horn with placenta accreta" 12/01/2005 - "The diagnosis of placenta percreta was not made until laparotomy" 08/01/1994 - "At laparotomy, placenta percreta was discovered" 08/01/1980 - "Laparotomy followed, revealing a ruptured twin interstitial pregnancy with placenta accreta and leiomyomata of the uterus." 05/01/2008 - "The placenta percreta became evident after laparotomy and the patients underwent total hysterectomy after infant expulsion" Get all the results and reference details, order at left...
29 Therapies and Procedures and 253 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>